Recurrence of Low-risk Non-muscle-invasive Bladder Cancer in Patients Who Did Not Receive Immediate Intravesical Chemotherapy

Cancer Diagnosis & Prognosis 2026 Open access

Read full text
Authors: Akinori Minato, Kazumasa Jojima, Shuki Watanabe, Yoshihiro Sugita, Yui Mizushima, Takuo Matsukawa, Rieko Kimuro, Katsuyoshi Higashijima, Yujiro Nagata, Ikko Tomisaki, Eiji Kashiwagi
DOI: 10.21873/cdp.10514
Cited by: 1

Abstract

Background/Aim: To reduce recurrence, immediate postoperative intravesical chemotherapy (IVC) is recommended for patients with low-risk non-muscle-invasive bladder cancer (NMIBC). This study evaluated recurrence outcomes in patients with low-risk NMIBC who did not receive immediate IVC and the potential benefit of introducing this approach. Patients and Methods: We retrospectively analyzed 100 patients with low-risk NMIBC who were selected from 1,845 patients who underwent transurethral resection of bladder tumor at our institution. According to international guidelines, low-risk was defined as primary, single, solitary (

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Urinary Bladder and Prostate Research Urinary and Genital Oncology Studies

Publication details

Journal / source
Cancer Diagnosis & Prognosis
Publisher
International Institute of Anticancer Research
Volume
6
Issue
1
Pages
135–143
Publication date
3 January 2026
Language
EN